Working Groups and Task Forces Clause Samples

Working Groups and Task Forces. A. Working Groups: The Steering Committee shall appoint necessary Working Groups for continuing duties to enact project business. 1. Working Groups shall be comprised of Member Representatives and Personal Members who elect to participate. 2. Working Groups shall be chaired by a Coordinator, who shall be elected in accordance with the procedures in Section VIII. Working Group Coordinators shall serve a term of three years. 3. A Working Group can be terminated by a majority vote of the Steering Committee.
View SourceView Similar (5)
Working Groups and Task Forces. A. Working Groups: The Steering Committee shall establish Working Groups as needed to enact TRAIL business on a continuing basis. 1. Working Groups shall be chaired by a Coordinator, who shall be jointly appointed by the Chair and Vice-Chair/Chair-Elect of TRAIL, in consultation with the Steering Committee. Working Group Coordinators shall normally serve a term of two years; reappointment is permitted. In the case of newly formed Working Groups, the Coordinator shall serve until the second TRAIL Annual Meeting after the appointment was made. In all other cases, appointments begin immediately following the TRAIL Annual Meeting. The Chair of TRAIL shall stagger the appointments of the Working Group Coordinators to ensure a measure of continuity within the Steering Committee each year. 2. Working Groups shall be comprised of participants from Member organizations who elect to take part in the activities of that Group. 3. A Working Group can be established, dissolved or suspended by a majority vote of all Steering Committee members. 4. Working Group Coordinators serve on the TRAIL Steering Committee and are expected to participate in the TRAIL Steering Committee’s meetings, as well as the TRAIL Annual Meeting each spring.
View SourceView Similar (3)
Working Groups and Task Forces. A. Working Groups: The Advisory Committee shall designate standing Working Groups for continuing duties to enact project business. 1. Working Groups shall be comprised of Member Representatives who elect to participate. 2. Working Groups shall be chaired by a Coordinator, who shall be elected in accordance with the procedures in Section VIII. Working Group Coordinators shall serve a term of three years. 3. Elected Coordinators of standing Working Groups shall serve on the Advisory Committee for the period of their elected terms. 4. A Working Group can be terminated by a majority vote of the Advisory Committee.
View Source

Related to Working Groups and Task Forces

  • Working Groups From time to time, a Joint Committee may establish and delegate duties to sub-committees or directed teams (each, a “Working Group”) on an “as-needed” basis to oversee particular projects or activities (e.g., joint project team, joint finance group, or joint intellectual property group). Each such Working Group shall be constituted and shall operate as the Joint Committee determines; provided, that each Working Group shall have equal representation from each Party, unless otherwise mutually agreed. Working Groups may be established on an ad hoc basis for purposes of a specific project or on such other basis as the Joint Committee may determine. Each Working Group and its activities shall be subject to the oversight, review and approval of, and shall report to, the Joint Committee that formed said Working Group. In no event shall the authority of the Working Group exceed that specified for the Joint Committee that formed the Working Group. All decisions of a Working Group shall be by unanimous agreement. Any disagreement between the designees of AbbVie and Ablynx on a Working Group shall be referred to the Joint Committee that formed the Working Group for resolution.

  • Working Group 1. The Parties hereby establish a Working Group on Temporary Entry for Business Persons, which shall meet at least once every 3 years or on request of the Free Trade Commission to consider any matter arising under this Chapter. 2. The Working Group's functions shall include: (a) to review the implementation and operation of this Chapter; (b) to consider the development of measures to further facilitate temporary entry of business persons on a reciprocal basis; (c) the identification of measures that affect the temporary entry of business persons under this Chapter; and (d) the observance of the issues established under Article 121 (Cooperation).

  • Development Responsibilities From and after the Effective Date, BMS shall assume sole responsibility for the Development of Compounds and Products in the Field in the Territory during the Term at its own cost and expense (including responsibility for all funding, resourcing and decision-making, subject to Sections 3.3 and 3.4), except with respect to the performance by Ambrx of the Research Program activities assigned to Ambrx pursuant to the Research Plan and as otherwise may be agreed upon by the Parties in writing. BMS, by itself or through its Affiliates and Sublicensees, shall use Diligent Efforts to Develop a Compound or Product in the Field in accordance with the Development Plan for the purpose of obtaining a Regulatory Approval in each Major Market [***]. For clarity, it is understood and acknowledged that Diligent Efforts in the Development of Compounds and Products may include sequential implementation of Clinical Trials and/or intervals between Clinical Trials for data interpretation and clinical program planning and approval.

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.